Simed Medical breaks ground on vascular intervention device R&D and production base in Nanjing

Simed Medical, a subsidiary of Xinwei Medical, broke ground on a 1.34 billion yuan vascular intervention device R&D and production project in the Nanjing Biomedical Valley, Jiangsu Province. The facility will produce 800,000 femoral artery closure devices and 200,000 embolic coils annually.

“10月13日，思脉德医疗血管介入医疗器械研发及生产项目在江北新区南京生物医药谷开工。”js.news.cn

• 1 source
• js.news.cn新基地开工 思脉德血管介入医疗器械新项目再投江北新区_新华网江苏频道Oct 13, 2026

Summarized from public sources; check the original articles before acting on it.